Chargement en cours...
Effective control of sickle cell disease with hydroxyurea therapy
OBJECTIVE: Hemoglobin F augmentation is another approach to treat sickle cell disease (SCD). This study evaluates the efficacy and impact of Hydroxyurea (HU) on fetal hemoglobin (HbF) and other hematological parameters, which result in decreasing the painful crisis and lower hospital admissions. MAT...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2885637/ https://ncbi.nlm.nih.gov/pubmed/20606834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.62409 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|